Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer-Reference-Cited by-同舟云学术

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer

Published:2021-10 Issue: Volume: Page:
ISSN:2319-4170
Container-title:Biomedical Journal
language:en
Short-container-title:Biomedical Journal

Author:

Chen Wei-Chun,Huang Huei-Jean,Yang Lan-Yan,Pan Yu-Bin,Huang Kuan-Gen,Lin Cheng-Tao,Chen Min-Yu,Tang Yun-Hsin,Chang Ting-Chang,Lai Chyong-Huey,Chou Hung-Hsueh

Funder

Chang Gung Memorial Hospital

Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Ovarian cancer: an integrated review;Stewart;Semin Oncol Nurs,2019

2. Cancer registry annual report;Taiwan DoH,2009

3. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N Engl J Med,2006

4. Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study;Landrum;Gynecol Oncol,2013

5. DNA lesions in hyperthermic cell killing: effects of thermotolerance, procaine, and erythritol;Jorritsma;Radiat Res,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;World Journal of Clinical Cases;2024-09-26

2. Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study;Journal of the Formosan Medical Association;2024-08

3. The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis;Journal of Personalized Medicine;2024-07-11

4. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT);Journal of Gynecologic Oncology;2024

5. Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods;International Journal of Gynecologic Cancer;2023-09-05